Filter
2003
Filtered Results: 2003
Text search:
World
Health
Organization,
Regional
Office
for
Africa.
Ministry
of
Health,
Botswana
Featured
Recommendations
163
New Publications
602
Language
Document type
No document type
1199
Studies & Reports
349
Guidelines
195
Manuals
97
Strategic & Response Plan
85
Training Material
39
Situation Updates
21
Fact sheets
9
Resource Platforms
5
Infographics
2
App
1
Online Courses
1
Countries / Regions
Ethiopia
92
Kenya
92
Sierra Leone
80
Global
77
Uganda
67
Liberia
66
Africa
57
Zambia
55
Tanzania
48
Nigeria
44
Malawi
44
Ghana
41
Rwanda
33
India
31
Namibia
31
Guinea
28
Western and Central Europe
26
Lesotho
25
Nepal
22
Congo, Democratic Republic of
21
South Africa
21
Senegal
20
South Sudan
19
Mozambique
18
East and Southern Africa
18
Zimbabwe
16
Eswatini/ Swaziland
15
Asia
15
Ukraine
14
West and Central Africa
14
Latin America and the Carribbean
14
Syria
13
Botswana
13
Middle East and North Africa
13
Cameroon
12
Bangladesh
11
Yemen
11
Somalia
10
Central African Republic
10
Madagascar
10
Myanmar / Burma
10
South–East Asia Region
10
Burkina Faso
8
Pakistan
8
Cambodia
8
Mali
7
Benin
7
Eastern Europe
7
Afghanistan
6
China
6
Haiti
5
Jordan
5
Thailand
5
Indonesia
5
Sudan
5
Brazil
5
Togo
4
Gambia
4
Sri Lanka
4
Eastern Europe and Central Asia
4
Côte d’Ivoire / Ivory Coast
3
Philippines
3
Iraq
3
Lebanon
3
Chad
3
Peru
3
Burundi
3
Angola
3
Iran
3
Mauritius
3
Guinea-Bissau
2
Germany
2
Papua New Guinea
2
Colombia
2
Greece
2
Western Pacific Region
2
Venezuela
2
Djibouti
2
Laos
2
Kazakhstan
2
Vietnam
2
Bosnia and Herzegovina
2
Morocco
1
USA
1
Saudi Arabia
1
Niger
1
Turkey
1
Mauritania
1
Vanuatu
1
North Macedonia
1
Serbia
1
Ecuador
1
Libya
1
Mexico
1
Solomon Islands
1
Palestine
1
North Korea
1
Albania
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Qatar
1
Bulgaria
1
Estonia
1
Moldova
1
Kyrgyzstan
1
Georgia
1
North America
1
Gabon
1
Turkmenistan
1
Japan
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
806
Clinical Guidelines
131
Public Health
115
Women & Child Health
103
Key Resources
88
Capacity Building
38
Pharmacy & Technologies
15
Toolboxes
HIV
165
Mental Health
123
COVID-19
117
Disability
98
Ebola
92
Rapid Response
90
TB
87
Planetary Health
77
AMR
64
Conflict
48
Caregiver
48
Refugee
45
Global Health Education
41
NTDs
37
Pharmacy
36
Health Financing Toolbox
22
NCDs
20
Natural Hazards
17
Cholera
14
Polio
9
Zika
9
Specific Hazards
6
Social Ethics
5
South Sudan
1
Typhoon
1
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries ... Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedi...
Updated to Reflect the 2009 Medical Eligibility Criteria of the World Health Organization
This technical report presents the results of a cross-sectional survey conducted in Sarajevo, the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina, between June and August 2017, as part ...
Bioethics 519 (online) doi:10.1111/bioe.12145 Volume 29 Number 8 2015 pp. 488–596;
Pandemic plans recommend phases of response to an emergent infectious disease (EID) outbreak, and are primarily aimed at preventing and mitigating human-to-human ...
The "Stories from the field" document by the WHO Regional Office for the Eastern Mediterranean shares effective strategies from the Eastern Mediter...
Regional Action Plan for HIV in South-East Asia (2017-2021)
The major areas of focus for the plan will be:
- Social mobilization and community empowerment (health promotion & education ... disease prevention);
- Promotion of access to safe water, good sanitation and hygiene;
- Surveillance and laboratory confirmation of outbreaks;
- Prompt case management and infection control;
- Complementary use of oral cholera vaccine (OCV) for cholera endemic communities; and
- Coordination and stewardship between and for all actors.
- Monitoring, supervision, evaluation and operation research to ensure continued improvement in service delivery.
- Social mobilization and community empowerment (health promotion & education ... disease prevention);
- Promotion of access to safe water, good sanitation and hygiene;
- Surveillance and laboratory confirmation of outbreaks;
- Prompt case management and infection control;
- Complementary use of oral cholera vaccine (OCV) for cholera endemic communities; and
- Coordination and stewardship between and for all actors.
- Monitoring, supervision, evaluation and operation research to ensure continued improvement in service delivery.
Since the release of the first volume in May 2020, the COVID-19 pandemic has continued to rage around the world. By mid-March, 2021, countries around the globe had reported over 123 million cases—...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support ... the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and outcomes relating to the pharmaceutical sector in Kenya.
This technical guidance outlines current evidence, knowledge and best practice relating to incidences of violence and injuries among refugees and migrants in the WHO European Region. It highlights key principles, summarizes priority actions and chal...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the ach...
The immediate objective of the country visit to Cameroon was to ensure that the country is as operationally ready as possible to effectively and safely detect, investigate and report potential Ebola virus disease cases and to mount an effective res...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal ... coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at strengthening primary health care and health systems, increasing immunization coverage, improving global health security, fighting antimicrobial resistance and advocating for the rights of persons with disabilities. It will complement other global control strategies, such as those addressing sepsis, pneumonia, tuberculosis and HIV. Implementation will be a challenge for all countries across the world, but especially in resource-poor settings where the burden of meningitis is greatest. The targets for the visionary and strategic goals will be adapted to regional and local contexts.
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part ... monitoring this progress, countries have adopted the Every Newborn Tracking Tool. This report presents a compilation of the data collated by the Every Newborn Tracking Tool in 2016, when 51 countries adopted the tool; it also spotlights examples of specific country activity for each National Milestone. Finally, Global Milestones for 2020 were part of the Every Newborn Action Plan to guide global and regional work in support of country efforts and this report highlights relevant progress towards those Global Milestones.
